Fore Genomics has launched a premium generic health screening test designed for newborns, infants and children. Focusing on newborns and children, a simple cheek swab sample provides doctors and parents with valuable genetic insight into a child’s potential for future diseases based on their DNA.
Backed by the reliability of CLIA-certified and CAP-approved labs, FORESITE 360 is designed to offer a complete genetic profile of your child, unlocking a lifetime of health insights. FORESITE 360 incorporates ongoing re-analysis of DNA, allowing doctors to take practical steps toward managing any detected medical conditions. Without adding a single item to their to-do list, clinicians can now add value for their patients with leading-edge sequencing, high-quality genetic counseling, and annually updated analysis.
Company Details
- Employees
- 10
- Founded
- -
- Address
- 4225 Executive Square,
- Industry
- Hospitals And Health Care
- NAICS
-
Health Care and Social AssistanceSocial Assistance
- Website
- https://foregenomics.com/
- Keywords
- Whole Genome Sequencing, Newborn Genome Sequencing, Applied Genomics, Newborn Screening, WGS, NBS, Genomics, DNA, Longitudinal Health, Pharmacogenomics, Personalized Healthcare.
- HQ
- La Jolla, California
Fore Genomics Questions
Fore Genomics's website is https://foregenomics.com/
Fore Genomics's LinkedIn profile is https://www.linkedin.com/company/foregenomics
Fore Genomics has
10 employees.
View email and phone details for 10
employees at Fore Genomics.
Fore Genomics's industry is
Hospitals and Health Care
Fore Genomics's top competitors are
Toyow,
16vc,
Novo Genomics,
New York Genome Center,
Assetra,
Inocras Inc.,
Pacbio,
Rare Genomics Institute,
Genembryomics,
Fulcrum Genomics Llc.
Fore Genomics's categories are Hospitals and Health Care
Fore Genomics's founding year is 2021
